Fosun Pharma and Handan Moluodan build a new traditional Chinese medicine platform

In December 23^rd, 2009, Fosun Pharmaceutical Co., ltd and Handan Moluodan Pharmaceutical Co., Ltd (abbreviated as Moluodan Pharma ) held a formal grand agreement signing ceremony in Handan Hotel in Handan. According to the agreement, Fosun will cooperate with Moluodan Parma in a wide range of areas such as product marketing, new drug development and talent training via the ways like increasing investment to enlarge shares and accepting transferred shares.

Fosun has great confidence in the development potential of Moluodan Pharma. In the one hand, with a pharmaceutical management history of several decades, Muolodan Pharma not only possesses a healthy production and quality control system, but also has a very good market foundation, gaining certain popularity in its product brands and a huge development space.

; on the other hand, the company has an excellent team which has been working on strengthening the management continuously for many years and valuing quality. It turned an old state-owned enterprise which almost went bankrupt into a well-known enterprise in the pharmaceutical field of the whole nation and a major enterprise in the province.

What s more, the cooperation between the two can reach a win-win situation through complementation of each other s advantages. Fosun can also take the golden opportunity to build a brand new development platform agreeing with the more modernized traditional Chinese medicine industry thus to take part in the development of the traditional Chinese medicine industry all around, perfect the traditional Chinese medicine section of Fosun and make up for the weakness of the section.

Muolodan Pharma was established in 1965 and was transformed as a whole into a joint-stock enterprise in September, 2009, becoming an famous old traditional Chinese medicine enterprise in homeland. The company has a capability of producing seven major drugs, 115 reserve products with code number approved by SFDA and Muolodan --national protective variety of traditional Chinese medicines, medicine within the scope of health insurance and product with proprietary technology, which is used to cure atrophic gastritis and very popular among the public due to its unique curative effect.

We hope to achieve fast breakthrough and development through cooperation with Fosun and increasing investment in the market and hope to be able to build a modern Muolodan traditional Chinese medicine park to develop Molodan Pharma into a world famous enterprise, realize distinct increase in taxation, create more job opportunities and finally to achieve the maximum gain by the government, employees and share holders. said the president of the Board of directors of Moluodan Pharma in the signing ceremony.

Earlier, Moluodan Pharma just finished a celebration for establishing a joint-stock system at the beginning of the same month and transformed the former Handan Pharmaceutical Co., Ltd into Handan Molodan Pharmaceutical Co, Ltd. This system transformation is a significant measure taken by Handan Pharmaceutical Co., Ltd in order to execute the brand strategy taking its leading product Muolodan as the dominant product, symbolizing the further deepening of the reform on enterprise joint-stock system.

Guo Dajian, the Mayor of Handan Municipality expressed his welcome to Fosun and thought highly of the company. The cooperation between Shanghai Fosun and Molodan Pharma will help both parties to exert their respective advantages and expand and strengthen the brand Muolodan and be of great significance to the adjustment of industry structure in Handan.